Clinical Report: Neoadjuvant Chemotherapy for Stage IVA Thymoma

Overview

This case study discusses a 32-year-old woman with stage IVA thymoma, myasthenia gravis, and systemic lupus erythematosus. Neoadjuvant chemotherapy was administered prior to surgical intervention.

Background

Thymomas are rare tumors associated with autoimmune diseases, particularly myasthenia gravis. The coexistence of thymoma with systemic lupus erythematosus complicates diagnosis and management. Evidence regarding the role of neoadjuvant therapy in advanced thymoma is limited.

Data Highlights

No numerical data or trial data provided in the article.

Key Findings

• A 32-year-old woman presented with stage IVA thymoma and concurrent autoimmune diseases.
• Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide, followed by carboplatin and paclitaxel) was administered.
• Radiographic assessment showed tumor regression and changes in pleural lesions.
• Complete surgical resection was achieved with negative margins following neoadjuvant therapy.
• Postoperative radiotherapy was administered.

Clinical Implications

This case illustrates the management of advanced thymoma in patients with concurrent autoimmune conditions.

Conclusion

Neoadjuvant chemotherapy can facilitate surgical resection of advanced thymoma in patients with concurrent autoimmune diseases.

Related Resources & Content

1. Clinical Rheumatology, 2020 -- Exploring Autoimmunity: The Relationship Between Thymoma, Thymectomy, and Systemic Lupus Erythematosus
2. Updates in Surgery, 2025 -- Expression of programmed death-ligand 1 in thymomas following surgical resection
3. Frontiers in Oncology, 2026 -- Optimising individualised treatment decisions for locally advanced thymoma: precision selection of minimally invasive surgery and postoperative adjuvant radiotherapy
4. Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
5. A real-world cohort study comparing chemotherapy and surgery in the treatment of stage IVA thymomas with pleural dissemination - Zhang - Mediastinum
6. Frontiers in Oncology — Feasibility of neoadjuvant immunochemotherapy in potentially resectable non-small cell lung cancer: a single-arm meta-analysis
7. Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
8. A real-world cohort study comparing chemotherapy and surgery in the treatment of stage IVA thymomas with pleural dissemination - Zhang - Mediastinum
9. Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors - ScienceDirect